Key Insights

Highlights

Treatment Research

4 treatments under study, led by Magventure Magpro Transcranial Magnetic Stimulation Tms System Sham

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1/2 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT07113067Phase 1/2Recruiting

Accelerated rTMS vs. Sham for Stroke Apathy

NCT05393492Not ApplicableRecruiting

Regulating Emotions and Behaviors After Brain Injury

Showing all 2 trials

Research Network

Common Treatments

  • Magventure Magpro Transcranial Magnetic Stimulation Tms System Sham1
  • Brainsight Neuronavigation System1
  • Dialectical Behavior Therapy And Radically Open Dialectical Behavior Therapy1
  • Magventure Magpro Transcranial Magnetic Stimulation Tms System Active1

Active Sponsors

  • Medical University of South Carolina1
  • University Hospital, Strasbourg, France1

Top Investigators

Related Conditions

  • Abulia1
  • Motivation1
  • Brain Tumor After Recovery1
  • Meningitis1
  • Cerebral Anoxia1

Activity Timeline